Literatur
-
1
Rascol O, Brooks D J, Korczyn A D. et al .
A five-year study of the incidence of dyskinesia in patients with early Parkinson's disease who were treated with ropinirole or levodopa. 056 Study Group.
N Engl J Med.
2000;
342
1484-1491
-
2
The Parkinson Study Group.
Pramipexole versus levodopa as initial treatment for Parkinson disease.
JAMA.
2000;
284
1931-1938
-
3
Oertel W H.
Pergolide versus levo-dopa (PELMOPET). Abstrakt (ohne Text).
Mov Disord.
2000;
15, Suppl 3
4
-
4
The Parkinson Study Group.
Effects of tocopherol and deprenyl on the progression of disability in early Parkinson's disease.
N Engl J Med.
1993;
328
176-183
-
5
Fahn S.
Is levodopa toxic?.
Neurology.
1996;
47, Suppl 3
184-195
-
6
Olanow C W, Hauser R A, Gauger L. et al .
The effect of deprenyl and levodopa on the progression of Parkinson's disease.
Ann Neurol.
1995;
38
771-777
-
7
Larsen J P, Boas J, Erdal J E. and the Norwegian-Danish Study Group .
Does selegiline modify the progression of early Parkinson's disease? Results from a five-year study.
Eur J Neurol.
1999;
6
539-547
-
8
Reichmann H, Sommer U, Fuchs G. et al .
Workshop IV: Drug treatment guidelines for the long-term management of Parkinson's disease.
J Neurol.
2000;
247, Suppl 4
S IV/40-IV/41
-
9
Spieker S, Loschmann P, Jentgens C. et al .
Tremorlytic activity of budipine; a quantitative study with long-term tremor recordings.
Clin Neuropharmacol.
1995;
18
266-272
-
10
Künig G, Pogarell O, Möller J C. et al .
Pramipexol, a nonergot dopamine agonist, is effective against rest tremor in intermediate to advanced Parkinson's disease.
Clin Neuropharmacol.
1999;
22
301-305
-
11
Dubois B, Pillon B, Lhermitte F, Agid Y.
Cholinergic deficiency and frontal dysfunction in Parkinson's disease.
Ann Neurol.
1990;
28
117-121
-
12
Mouradian M M, Heuser I JE, Baronti F. et al .
Modification of central dopaminergic mechanisms by continous levodopa therapy for advanced Parkinson's disease.
Ann Neurol.
1990;
27
18-23
-
13
Kostic V, Przedborski S, Flaster E, Sternic N.
Early development of levodopa-induced dyskinesias and response fluctuations in young-onset Parkinson's disease.
Neurology.
1991;
41
202-205
-
14
Koller W C, Hutton J T, Tolosa E, Capilldeo R.
Immediate-release and controlled-release carbidopa/levodopa in PD: a 5-year randomized multicenter study. Carbidopa/Levodopa Study Group.
Neurology.
1999;
53
1012-1019
Prof. Dr. med. Heinz Reichmann
Klinik und Poliklinik für Neurologie
Medizinische Fakultät Carl Gustav Carus
Technische Universität Dresden
Fetscherstraße 74
01307 Dresden
